|
|
histone modification
|
GO:0016570 |
159 |
0.210
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.176
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.171
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.156
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.140
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.138
|
|
|
|
axon target recognition
|
GO:0007412 |
4 |
0.127
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.126
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.109
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.105
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.105
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.102
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.102
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.097
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.096
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.094
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.087
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.085
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.084
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.082
|
|
|
|
cajal body organization
|
GO:0030576 |
1 |
0.078
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.072
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.070
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.070
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.065
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.064
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.059
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.057
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.055
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.055
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.055
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.054
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.054
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.053
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.052
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.051
|
|
|
|
natural killer cell activation
|
GO:0030101 |
44 |
0.051
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.051
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.050
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.049
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.048
|
|
|
|
dna packaging
|
GO:0006323 |
30 |
0.047
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.045
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.044
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.043
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.043
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.043
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.042
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.042
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.039
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.039
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.039
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.039
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.039
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.038
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.037
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.036
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.035
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.035
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.034
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.034
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.034
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.034
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.033
|
|
|
|
mitotic chromosome condensation
|
GO:0007076 |
1 |
0.033
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.032
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.032
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.032
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.031
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.031
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.031
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.031
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.031
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.030
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.030
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.030
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.030
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.030
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.030
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.029
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.029
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.029
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.028
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.028
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.028
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.028
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.027
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.027
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.026
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.026
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.026
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.026
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.026
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.026
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.026
|
|
|
|
protein ubiquitination involved in ubiquitin dependent protein catabolic process
|
GO:0042787 |
25 |
0.026
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.026
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.026
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.026
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.025
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.025
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.025
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.025
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.024
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.024
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.024
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.024
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.024
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.024
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.023
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.023
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.023
|
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.023
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.022
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.022
|
|
|
|
microtubule nucleation
|
GO:0007020 |
2 |
0.022
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.022
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.022
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.022
|
|
|
|
natural killer cell differentiation
|
GO:0001779 |
21 |
0.022
|
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.022
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.022
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.022
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.021
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.021
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.021
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.021
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.021
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.021
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.021
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.021
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.020
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.020
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.020
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.020
|
|
|
|
microtubule polymerization or depolymerization
|
GO:0031109 |
26 |
0.020
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.020
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.020
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.020
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.020
|
|
|
|
microtubule organizing center organization
|
GO:0031023 |
28 |
0.020
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.019
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.019
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.019
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.019
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.019
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.019
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.019
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.018
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.018
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.018
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.018
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.018
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.018
|
|
|
|
chromatin assembly or disassembly
|
GO:0006333 |
16 |
0.018
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.018
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.018
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.018
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.018
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.018
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.017
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.017
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.017
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.017
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.017
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.017
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.017
|
|
|
|
chromatin remodeling at centromere
|
GO:0031055 |
2 |
0.017
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.017
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.017
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.017
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.017
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.016
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.016
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.016
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
33 |
0.016
|
|
|
|
spindle assembly involved in female meiosis i
|
GO:0007057 |
2 |
0.016
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.016
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.016
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.016
|
|
|
|
dna templated transcription termination
|
GO:0006353 |
4 |
0.016
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.016
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.016
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.016
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
28 |
0.016
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.016
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.016
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.015
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.015
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.015
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.015
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.015
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.015
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.015
|
|
|
|
spindle assembly involved in meiosis
|
GO:0090306 |
4 |
0.015
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.015
|
|
|
|
definitive hemopoiesis
|
GO:0060216 |
20 |
0.015
|
|
|
|
leukocyte tethering or rolling
|
GO:0050901 |
3 |
0.015
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.015
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.015
|
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.015
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.015
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.015
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.015
|
|
|
|
establishment of meiotic spindle orientation
|
GO:0051296 |
1 |
0.015
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.014
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.014
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.014
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.014
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.014
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.014
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.014
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
48 |
0.014
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.014
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.014
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.014
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.014
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.014
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.014
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.014
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.014
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.013
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
52 |
0.013
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.013
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.013
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.013
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.013
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.013
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.013
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.013
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.013
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.013
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.013
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.013
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.013
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.013
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.013
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.013
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.013
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.013
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.013
|
|
|
|
regulation of hepatocyte proliferation
|
GO:2000345 |
6 |
0.013
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.012
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.012
|
|
|
|
centrosome separation
|
GO:0051299 |
4 |
0.012
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.012
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.012
|
|
|
|
centrosome organization
|
GO:0051297 |
26 |
0.012
|
|
|
|
mitotic sister chromatid segregation
|
GO:0000070 |
14 |
0.012
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.012
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.012
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.012
|
|
|
|
defecation
|
GO:0030421 |
1 |
0.012
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.012
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.011
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.011
|
|
|
|
regulation of hematopoietic progenitor cell differentiation
|
GO:1901532 |
18 |
0.011
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.011
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.011
|
|
|
|
regulation of planar cell polarity pathway involved in axis elongation
|
GO:2000040 |
3 |
0.011
|
|
|
|
regulation of synapse structural plasticity
|
GO:0051823 |
4 |
0.011
|
|
|
|
cellular response to interferon gamma
|
GO:0071346 |
25 |
0.011
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.011
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.011
|
|
|
|
microtubule polymerization
|
GO:0046785 |
12 |
0.011
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.011
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.011
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.011
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.011
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.011
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.011
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.011
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.011
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.011
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.011
|
|
|
|
maintenance of protein location in nucleus
|
GO:0051457 |
2 |
0.011
|
|
|
|
chromatin assembly
|
GO:0031497 |
13 |
0.011
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.011
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.010
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.010
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.010
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.010
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.010
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.010
|
|
|
|
sertoli cell development
|
GO:0060009 |
15 |
0.010
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.010
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.010
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.010
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.010
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.010
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.010
|
|